Cellectar Biosciences (CLRB) Return on Capital Employed [ROCE] (2011 - 2026)
Cellectar Biosciences' Return on Capital Employed [ROCE] came in at -115.57% for Q2 2026, up 312.23 percentage points from -427.80% a year earlier.
Powered by 
Analysis
Cellectar Biosciences (CLRB) Return on Capital Employed [ROCE] (2011 - 2026) Analysis & Trends
For FY2025, Cellectar Biosciences' Return on Capital Employed [ROCE] was -148.48%, up 403.10 percentage points from FY2024.
- Return on Capital Employed [ROCE] carries a five-year change of -100.54 percentage points (FY2020 to FY2025).
- Going back by year, Return on Capital Employed [ROCE] was -551.59% in FY2024, -161.02% in FY2022 (-106.10 pp) and -54.92% in FY2021 (-6.97 pp).
- The Q2 2026 figure represents the highest quarterly Return on Capital Employed [ROCE] since Q2 2022.
- Year-over-year, Return on Capital Employed [ROCE] increased in three of the last four quarters, with an average year-over-year change of +47.44 percentage points.
- The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2026 (a gain of 312.23 percentage points), and the weakest in Q1 2023 (a drop of 382.19 percentage points).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 11.86% |
| 10 | Cellectar Biosciences | 22.87 Mn | 22.87 Mn | - | -115.57% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -115.57% |
| Dec 31, 2025 | -228.58% |
| Sep 30, 2025 | -324.73% |
| Jun 30, 2025 | -427.80% |
| Mar 31, 2025 | -313.33% |
| Dec 31, 2024 | -235.40% |
| Sep 30, 2024 | -396.03% |
| Jun 30, 2024 | -227.22% |
| Mar 31, 2023 | -469.95% |
| Dec 31, 2022 | -321.83% |
| Sep 30, 2022 | -176.33% |
| Jun 30, 2022 | -112.85% |
| Mar 31, 2022 | -87.77% |
| Dec 31, 2021 | -67.81% |
| Sep 30, 2021 | -52.80% |
| Jun 30, 2021 | -41.97% |
| Mar 31, 2021 | -34.12% |
| Dec 31, 2020 | -42.34% |
| Sep 30, 2020 | -81.20% |
| Jun 30, 2020 | -115.27% |
API Access
Cellectar Biosciences Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CLRB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "CLRB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=CLRB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();